A seasoned clinical research executive with expertise in biostatistics, leadership, and team building. Dr. Bubb has contributed to over 100 therapeutic product developments and led regulatory submissions (e.g., IND, NDA, BLA, 510k). She has extensive experience across therapeutic areas and has served on monitoring committees (DMC, SMC, DSMB) in various capacities.

An accomplished biostatistics leader with over 25 years of experience across clinical research organizations, biotech firms, and independent consulting. Lori has served in senior roles at various companies, specializing in statistical consulting and the development of innovative designs. She has contributed to projects across diverse therapeutic areas, including oncology and rare diseases, and has a proven track record in supporting regulatory submissions and advancing drug development
initiatives.

Ariana is a biochemist by training who combines her site and vendor side experiences to build data ecosystems that bridge science, technology, and operations together. As Executive Director of Data Management, she leads Altru’s team delivering trusted data through modern designs and strong governance. Her work advancing large-scale omics, electronic registries, and real-world data integration has improved how trials run and decisions get made. Above all, Ariana is fiercely committed to enabling teams to focus on what matters most: patients and science.

Katie is an accomplished clinical biostatistician with over a decade of experience supporting Phase I–III trials and medical device studies. She has expertise in statistical methodology, analysis dataset development, and investigator‑assessed endpoints across multiple therapeutic areas. She has contributed to regulatory submissions including INDs, NDAs, and 510(k)s, ensuring analyses are methodologically sound and aligned with regulatory expectations. Katie works closely with data management and statistical programming teams to deliver high-quality, submission-ready analyses.